Literature DB >> 26843117

Disposition of flavonoids via recycling: Direct biliary excretion of enterically or extrahepatically derived flavonoid glucuronides.

Min Zeng1,2, Rongjin Sun3,2,4,5, Sumit Basu2, Yong Ma2, Shufan Ge2, Taijun Yin2, Song Gao2, Jun Zhang1, Ming Hu3,2.   

Abstract

SCOPE: Enterohepatic recycling is often thought to involve mostly phase II metabolites generated in the liver. This study aims to determine if direct biliary excretion of extrahepatically generated glucuronides would also enable recycling. METHODS AND
RESULTS: Conventional and modified intestinal perfusion models along with intestinal and liver microsomes were used to determine the contribution of extrahepatically derived glucuronides. Glucuronidation of four flavonoids (genistein, biochanin A, apigenin, and chrysin at 2.5-20 μM) were generally more rapid in the hepatic than intestinal microsomes. Furthermore, when aglycones (at 10 μM each) were perfused, larger (1.7-9 fold) amounts of glucuronides were found in the bile than in the luminal perfusate. However, higher concentrations of glucuronides were not found in jugular vein than portal vein, and apigenin glucuronide actually displayed a significantly lower concentration in jugular vein (<1 nM) than portal vein (≈4 nM). A direct portal infusion of four flavonoid glucuronides (5.9-10.4 μM perfused at 2 mL/h) showed that the vast majority (>65%) of the glucuronides (except for biochanin A glucuronide) administered were efficiently excreted into the bile.
CONCLUSION: Direct biliary excretion of extrahepatically generated flavonoid glucuronides is a highly efficient clearance mechanism, which should enable enterohepatic recycling of flavonoids without hepatic conjugating enzymes.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Biliary excretion; Efficient; Enterohepatic recycling; Extrahepatically; Flavonoids

Mesh:

Substances:

Year:  2016        PMID: 26843117      PMCID: PMC5358014          DOI: 10.1002/mnfr.201500692

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  54 in total

Review 1.  Enterohepatic circulation: physiological, pharmacokinetic and clinical implications.

Authors:  Michael S Roberts; Beatrice M Magnusson; Frank J Burczynski; Michael Weiss
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Function of uptake transporters for taurocholate and estradiol 17beta-D-glucuronide in cryopreserved human hepatocytes.

Authors:  Yoshihisa Shitara; Albert P Li; Yukio Kato; Chuang Lu; Kiyomi Ito; Tomoo Itoh; Yuichi Sugiyama
Journal:  Drug Metab Pharmacokinet       Date:  2003       Impact factor: 3.614

Review 3.  Factors affecting the bioavailability of soy isoflavones in humans.

Authors:  Aedin Cassidy
Journal:  J AOAC Int       Date:  2006 Jul-Aug       Impact factor: 1.913

Review 4.  Biosynthesis of bile acids in mammalian liver.

Authors:  S Kevresan; K Kuhajda; J Kandrac; J P Fawcett; M Mikov
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Jul-Sep       Impact factor: 2.441

5.  Catechin is metabolized by both the small intestine and liver of rats.

Authors:  J L Donovan; V Crespy; C Manach; C Morand; C Besson; A Scalbert; C Rémésy
Journal:  J Nutr       Date:  2001-06       Impact factor: 4.798

6.  Determination of hepatic blood flow in the rat using sequential infusions of indocyanine green or galactose.

Authors:  G M Pollack; K L Brouwer; K B Demby; J A Jones
Journal:  Drug Metab Dispos       Date:  1990 Mar-Apr       Impact factor: 3.922

7.  Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats.

Authors:  E Bowey; H Adlercreutz; I Rowland
Journal:  Food Chem Toxicol       Date:  2003-05       Impact factor: 6.023

8.  Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1.

Authors:  Stefan Oswald; Jörg König; Dieter Lütjohann; Thomas Giessmann; Heyo K Kroemer; Christian Rimmbach; Dieter Rosskopf; Martin F Fromm; Werner Siegmund
Journal:  Pharmacogenet Genomics       Date:  2008-07       Impact factor: 2.089

Review 9.  Health benefits of soy isoflavonoids and strategies for enhancement: a review.

Authors:  Patrick McCue; Kalidas Shetty
Journal:  Crit Rev Food Sci Nutr       Date:  2004       Impact factor: 11.176

10.  Organic anion transporting polypeptides OATP1B1 and OATP1B3 and their genetic variants influence the pharmacokinetics and pharmacodynamics of raloxifene.

Authors:  Tina Trdan Lušin; Bruno Stieger; Janja Marc; Aleš Mrhar; Jurij Trontelj; Andrej Zavratnik; Barbara Ostanek
Journal:  J Transl Med       Date:  2012-04-25       Impact factor: 5.531

View more
  14 in total

1.  Hepatoenteric recycling is a new disposition mechanism for orally administered phenolic drugs and phytochemicals in rats.

Authors:  Yifan Tu; Lu Wang; Yi Rong; Vincent Tam; Taijun Yin; Song Gao; Rashim Singh; Ming Hu
Journal:  Elife       Date:  2021-07-01       Impact factor: 8.140

2.  Challenges and Opportunities with Predicting in Vivo Phase II Metabolism via Glucuronidation from in Vitro Data.

Authors:  Shufan Ge; Yifan Tu; Ming Hu
Journal:  Curr Pharmacol Rep       Date:  2016-11-08

Review 3.  Does Oral Apigenin Have Real Potential for a Therapeutic Effect in the Context of Human Gastrointestinal and Other Cancers?

Authors:  Eva F DeRango-Adem; Jonathan Blay
Journal:  Front Pharmacol       Date:  2021-05-18       Impact factor: 5.810

4.  Irinotecan-mediated diarrhea is mainly correlated with intestinal exposure to SN-38: Critical role of gut Ugt.

Authors:  Rongjin Sun; Lijun Zhu; Li Li; Wenjie Song; Xia Gong; Xiaoxiao Qi; Ying Wang; Romi Ghose; Song Gao; Ming Hu; Zhongqiu Liu
Journal:  Toxicol Appl Pharmacol       Date:  2020-05-05       Impact factor: 4.460

Review 5.  Cancer chemoprevention through dietary flavonoids: what's limiting?

Authors:  Haneen Amawi; Charles R Ashby; Amit K Tiwari
Journal:  Chin J Cancer       Date:  2017-06-19

Review 6.  Formononetin: A Review of Its Anticancer Potentials and Mechanisms.

Authors:  Kai-Ching Tay; Loh Teng-Hern Tan; Chim Kei Chan; Sok Lai Hong; Kok-Gan Chan; Wei Hsum Yap; Priyia Pusparajah; Learn-Han Lee; Bey-Hing Goh
Journal:  Front Pharmacol       Date:  2019-07-26       Impact factor: 5.810

7.  Enterohepatic Circulation and Pharmacokinetics of Genistin and Genistein in Rats.

Authors:  Ya-Yu Yang; Tung-Hu Tsai
Journal:  ACS Omega       Date:  2019-10-24

8.  Cellular and molecular alterations induced by low‑dose fisetin in human chronic myeloid leukemia cells.

Authors:  Anna Klimaszewska-Wiśniewska; Dariusz Grzanka; Paulina Czajkowska; Marta Hałas-Wiśniewska; Justyna Durślewicz; Paulina Antosik; Alina Grzanka; Maciej Gagat
Journal:  Int J Oncol       Date:  2019-10-02       Impact factor: 5.650

9.  Rapid intestinal glucuronidation and hepatic glucuronide recycling contributes significantly to the enterohepatic circulation of icaritin and its glucuronides in vivo.

Authors:  Yi Rong; Yifan Tu; Taijun Yin; Zhiyun Meng; Guifang Dou; Ming Hu
Journal:  Arch Toxicol       Date:  2020-09-11       Impact factor: 5.153

10.  Development and validation of an LC-MS/MS method for the quantification of flavonoid glucuronides (wogonoside, baicalin, and apigenin-glucuronide) in the bile and blood samples: Application to a portal vein infusion study.

Authors:  Yifan Tu; Lei Zhou; Li Li; Lu Wang; Song Gao; Ming Hu
Journal:  Anal Biochem       Date:  2020-04-13       Impact factor: 3.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.